Literature DB >> 1155084

Chemical pathology of Krabbe's disease. III. Ceramide-hexosides and gangliosides of brain.

M T Vanier, L Svennerholm.   

Abstract

Neutral ceramide-hexosides and gangliosides in cerebral cortex and white matter of children who had died in Krabbe's disease were quantitatively isolated and characterized. The concentrations of galactosylceramides; lactosylceramides and glucosylceramides were normal or slightly increased in cerebral cortex, but all the three glycolipids were diminsihed in white matter, particularly the galactosylceramides. More complex ceramide-hexosides, globotriose, globotetraose and blood-group substance H, present in trace amounts in normal brain, were much more abundant in cerebral cortex and especially in white matter of brains affected by Krabbe's disease. The composition of the ceramide portion suggested that these glycolipids as well as a portion of the lactosylceramides and glucosylceramides were structural components of the globoid cell. The ganglioside distribution was severely altered. GD1a and GM1 were severely reduced in cerebral cortex and white matter, while GD1b and GT1 were slightly decreased in cerebral cortex, but increased in white matter. Normally minor brain gangliosides metabolically related to GD1b and GT1, i.e. GD2, GD3 and GM3, were strongly increased in cerebral cortex and in white matter. For the first time galactosylsphingosine (psychosine) was demonstrated in normal infant brain. In cerebral tissue affected by Krabbe's disease the concentration of psychosine was at least 10 times higher. The large increase in this cytotoxic substance might be the primary lesion in Krabbe's disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155084     DOI: 10.1111/j.1651-2227.1975.tb03896.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  13 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

2.  Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease.

Authors:  Je-Seong Won; Jinsu Kim; Manjeet Kaur Paintlia; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2013-02-21       Impact factor: 3.252

Review 3.  Cationic glycosphingolipids in neuronal tissues and their possible biological significance.

Authors:  Toshiyuki Hikita; Keiko Tadano-Aritomi; Naoko Iida-Tanaka; Steven B Levery; Ineo Ishizuka; Senitiroh Hakomori
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

4.  Physicochemical characterization of psychosine by 1H nuclear magnetic resonance and electron microscopy.

Authors:  L Orfi; C K Larive; S M LeVine
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

5.  The morphologic similarities of human and canine globoid leukodystrophy. Thin section and freeze-fracture studies.

Authors:  E J Yunis; R E Lee
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

Review 6.  Secondary lipid accumulation in lysosomal disease.

Authors:  Steven U Walkley; Marie T Vanier
Journal:  Biochim Biophys Acta       Date:  2008-12-09

7.  GC-EI-MS analysis of fatty acid composition in brain and serum of twitcher mouse.

Authors:  Assunta Zanfini; Elena Dreassi; Anna Berardi; Paola Piomboni; Elvira Costantino-Ceccarini; Alice Luddi
Journal:  Lipids       Date:  2014-09-11       Impact factor: 1.880

8.  The twitcher mouse: an ultrastructural study on the oligodendroglia.

Authors:  H Takahashi; H Igisu; K Suzuki; K Suzuki
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

Review 9.  On the role of natural killer cells in neurodegenerative diseases.

Authors:  Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2013-02-19       Impact factor: 4.546

10.  Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity.

Authors:  Christopher J Folts; Nicole Scott-Hewitt; Christoph Pröschel; Margot Mayer-Pröschel; Mark Noble
Journal:  PLoS Biol       Date:  2016-12-15       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.